Beta Bionics (NASDAQ:BBNX) Now Covered by Lake Street Capital
Lake Street Capital initiated coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $30.00 price target on the stock. Lake Street Capital’s price objective suggests a potential upside of 56.49% from the stock’s current […]
Lake Street Capital initiated coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $30.00 price target on the stock. Lake Street Capital’s price objective suggests a potential upside of 56.49% from the stock’s current […]
